Hindustantimes wants to start sending you push notifications. Click allow to subscribe

bharat biotech


TN to become first in country to administer Covid shots to children over 2 years

52,379,870 doses of the vaccine have been administered in Tamil Nadu till 7am on Wednesday.
Published on Oct 13, 2021 10:07 PM IST

WHO to take final decision on Covaxin nod next week

A woman receives a dose of Covaxin manufactured by Bharat Biotech (REUTERS)
Updated on Oct 06, 2021 02:49 AM IST

Bharat Biotech submits data from Covaxin's trials on children to DCGI: Report

Bharat Biotech International Limited's Covaxin (HT File Photo)
Published on Oct 03, 2021 10:30 AM IST

‘Next 6-8 weeks are important as…’: Guleria on how Covid cases can drop

AIIMS director Dr Randeep Guleria said that he is “hopeful” the approval of Covaxin by the WHO should happen soon. (ANI Photo)
Updated on Oct 01, 2021 06:26 PM IST

Working with WHO to get emergency use listing for Covaxin: Bharat Biotech

Bharat Biotech is working with the World Health Organization (WHO) to obtain Emergency Use Listing for Covaxin, its Covid vaccine. (PTI)
Updated on Sep 29, 2021 03:14 AM IST

‘Diligently working with WHO to obtain EUL at the earliest’, says Bharat Biotech

Covaxin is one among the three vaccines being used in India's immunisation programme against Covid-19.
Published on Sep 28, 2021 04:17 PM IST

Bharat Biotech completes phase 2/3 trials of Covaxin in children

Briefing on the production of Covaxin, Krishna Ella said that it would reach 55 million doses in October.
Published on Sep 21, 2021 04:19 PM IST

Covaxin's wait continues, WHO ‘delays’ emergency use nod till October 5

Bharat Biotech's Covaxin, India's first indigenous Covid-19 vaccine. 
Published on Sep 18, 2021 07:43 AM IST

Inappropriate to comment on WHO's Covaxin approval process: Bharat Biotech

The Phase 3 clinical trials data of Covaxin demonstrated 77.8 per cent efficacy.
Published on Sep 17, 2021 03:59 PM IST

Initial findings from Biotech's nasal vaccine show 'promising results': Govt

The vaccine is being developed with support from the department of biotechnology (DBT) and Biotechnology Industry Research Associate Council (BIRAC).
Published on Sep 09, 2021 08:55 PM IST

AIIMS to conduct Phase 2/3 trials of Bharat Biotech’s nasal Covid vaccine soon

A health worker collects a nasal sample from a passenger for COVID-19 test, at the Chhatrapati Shivaji Maharaj terminus in Mumbai.
Published on Sep 09, 2021 07:58 AM IST

Covaxin 65% efficient against Delta variant, 75 million doses supplied so far

Bharat Biotech committed last month to supply 500 million doses of Covaxin to the Union government.
Published on Aug 12, 2021 11:16 PM IST

Covid-19: Ocugen says Covaxin under 'active review' in Canada

Bharat Biotech's Covaxin (HT File Photo)
Published on Aug 07, 2021 04:28 PM IST

'Over 200 tests for every batch': Bharat Biotech on Covaxin quality concern

Bharat Biotech on Thursday issued a statement asserting that there is no quality concern regarding Covaxin.
Published on Aug 05, 2021 08:24 PM IST

Quality concerns delayed Covaxin supply, says top govt advisor

First few batches of Covaxin produced at Bharat Biotech's facility in Bengaluru were of unsatisfactory quality.
Published on Aug 03, 2021 02:58 PM IST

Covaxin effective against new Delta Plus variant, says study

Bharat Biotech in June said the final efficacy estimates, based on its phase 3 trials, showed Covaxin had an efficacy rate of 77.8% against the Sars-Cov-2 virus that most closely resembles the origin virus. (AFP)
Updated on Aug 03, 2021 01:59 AM IST

Rotavac 5D: Bharat Biotech's rotavirus vaccine receives WHO 'Prequalification'

Image used only for representative purpose
Published on Aug 02, 2021 06:45 PM IST

Will nasal vaccines offer maximum protection against Covid-19? What we know

Nasal vaccines against Covid-19 are likely to prevent the virus from entering through the nose, (Photo: Bharat Biotech)
Published on Aug 01, 2021 07:36 PM IST

Covaxin stares at an uncertain US launch

This guidance came, although Bharat Biotech hadn’t submitted its phase 3 data to Indian regulators.
Updated on Jul 26, 2021 04:54 AM IST

What went wrong in Bharat Biotech's Covaxin deal with Brazil? Explained

A day after Bharat Biotech distanced itself from its Brazil partner, its clinical trial in the country got suspended.
Published on Jul 24, 2021 03:29 PM IST

Bharat Biotech cancels Covaxin deals with two Brazil firms after graft row

Bharat Biotech says it has cancelled the agreement with Brazil’s Precisa Medicamentos for exporting Covaxin to the country.
Published on Jul 23, 2021 11:14 PM IST

Vaccine trials for kids: 2nd dose of Covaxin to be administered next week

Bharat Biotech's Covaxin (Bloomberg)
Published on Jul 19, 2021 07:40 PM IST

Covaxin's emergency use listing: All papers sent to WHO, says Bharat Biotech

A health worker prepares a dose of the Bharat Biotech Ltd. Covaxin vaccine at a Covid-19 vaccination center set up at the Delhi Municipal Corp.
Updated on Jul 13, 2021 01:55 AM IST

'Submitted all documents to WHO for EUL of Covaxin as of July 9': Bharat Biotech

Bharat Biotech's Covaxin (Sanchit Khanna/HT PHOTO)
Published on Jul 12, 2021 10:35 PM IST

News updates from HT: After Tirath exits, Uttarakhand BJP to meet today

Uttarakhand chief minister Tirath Singh Rawat’s tenure has been mired in controversy including one around his move to go ahead with Mahakumbh without taking adequate and effective steps. (PTI)
Updated on Jul 03, 2021 09:02 AM IST

Bharat Biotech says it received no advance payment from Brazil govt for Covaxin

Bharat Biotech said it has neither sent any vaccine to Brazil nor has received any money from the Brazil government.
Published on Jun 30, 2021 04:22 PM IST

Bharat Biotech may attend WHO pre-submission meeting on Covaxin

Bharat Biotech said that it expects approval for its Covid vaccine from the health organisation for emergency use listing during July to September.
Updated on Jun 23, 2021 09:35 AM IST

Monthly output of 25mn doses to continue till Aug: Bharat Biotech

The government has so far bought 85 million doses of Covaxin (10 through the PM Cares Fund and 75 directly), and placed advance orders (paying 30%) for an additional 190 million doses.
Updated on Jun 23, 2021 11:35 AM IST

Covaxin submits Phase 3 data to expert panel, claims 78% efficacy

Bharat Biotech is yet to release the data from any of the interim analyses of the clinical trials.
Updated on Jun 23, 2021 09:59 AM IST
This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.